We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Abbott Offers Fixes To Clear $25B St. Jude Deal In EU

Law360, New York (November 3, 2016, 7:19 PM EDT) -- Abbott Laboratories has offered remedies to alleviate concerns that its $25 billion cash-and-stock acquisition of medical device maker St. Jude Medical will harm competition in the European Union, according to a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.